Dr Reddy's launches drug to treat severe Covid

June 28, 2021 10:50

Dr Reddy's Laboratories has announced the commercial launch of 2-deoxy-D-glucose (2-DG), a drug for moderate to severe Covid-19 patients administered as an adjunct therapy to the existing standard care.

The emergency use approval for anti-Covid-19 therapeutic application of the drug was granted on May 1, 2021.

Dr Reddy's will supply to major government as well as private hospitals across India. In the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India.

2-DG manufactured by Dr Reddy's has a purity of 99.5 per cent and is being sold commercially under the brand name 2DGTM. The maximum retail price (MRP) of each sachet has been fixed at 990, with a subsidised rate offered to government institutions.

« Back to LIVE

TOP STORIES

Buried Art 370 in 'kabristan', Cong can't restore it: Modi

Modi referred to the Lok Sabha polls as a "Kurukshetra (battle)" in which "there is development on one hand and 'vote jihad' on the other".

Bundesliga: Unbeaten Bayer Leverkusen create history!

Bayer Leverkusen are the first team in the history of the Bundesliga to complete a full season without a loss.

'The boys in Indian team comfortable around Rohit'

Shikhar Dhawan believes the Indian players enjoy their game under the captaincy of Rohit Sharma.

HC restrains misuse of actor Jackie Shroff's name, voice without consent

The court said Shroff is a celebrity and this status inherently grants him certain rights over his personality and associated attributes.

F1: Verstappen equals Senna's pole record!

Red Bull's Max Verstappen equalled Ayrton Senna's record of eight pole positions in a row.